Minimal Change Disease: More Than a Podocytopathy?
作者信息
Maas Rutger J, Nijenhuis Tom, van der Vlag Johan
机构信息
Radboud University Nijmegen Medical Center, Nijmegen, Gelderland, The Netherlands.
出版信息
Kidney Int Rep. 2022 Mar 3;7(4):675-677. doi: 10.1016/j.ekir.2022.03.001. eCollection 2022 Apr.
Abstract
摘要
相似文献
1
Minimal Change Disease: More Than a Podocytopathy?微小病变病：不仅仅是一种足细胞病？
Kidney Int Rep. 2022 Mar 3;7(4):675-677. doi: 10.1016/j.ekir.2022.03.001. eCollection 2022 Apr.
2
Clinical-Morphological Features and Outcomes of Lupus Podocytopathy.狼疮性足细胞病的临床形态学特征及转归
Clin J Am Soc Nephrol. 2016 Apr 7;11(4):585-92. doi: 10.2215/CJN.06720615. Epub 2016 Mar 16.
3
Lupus podocytopathy: a distinct entity of lupus nephritis.狼疮性足细胞病：狼疮肾炎的一个独特实体。
J Nephrol. 2018 Oct;31(5):629-634. doi: 10.1007/s40620-017-0463-1. Epub 2017 Dec 22.
4
The Role of Parietal Epithelial Cells in the Pathogenesis of Podocytopathy.壁层上皮细胞在足细胞病发病机制中的作用
Front Physiol. 2022 Mar 11;13:832772. doi: 10.3389/fphys.2022.832772. eCollection 2022.
5
Is It Coincidence or Consequence for a Case with Antiphospholipid Antibody Syndrome Overlapping SLE to Develop an Immune Complex Nephropathy Followed by a Nonimmune Complex Podocytopathy?抗磷脂抗体综合征重叠系统性红斑狼疮的病例发生免疫复合物性肾病后又出现非免疫复合物性足细胞病，这是巧合还是必然结果？
Case Rep Nephrol. 2018 Jul 24;2018:6746473. doi: 10.1155/2018/6746473. eCollection 2018.
6
Delayed Onset Minimal Change Disease as a Manifestation of Lupus Podocytopathy.迟发性微小病变病作为狼疮性足细胞病的一种表现形式。
Clin Pract. 2021 Oct 6;11(4):747-754. doi: 10.3390/clinpract11040089.
7
Reduced Lon protease 1 expression in podocytes contributes to the pathogenesis of podocytopathy.足细胞中Lon蛋白酶1表达降低促成了足细胞病的发病机制。
Kidney Int. 2021 Apr;99(4):854-869. doi: 10.1016/j.kint.2020.10.025. Epub 2020 Nov 10.
8
Recurrent podocytopathy in a patient with systemic lupus erythematosus.一名系统性红斑狼疮患者的复发性足细胞病
SAGE Open Med Case Rep. 2017 Feb 23;5:2050313X17695997. doi: 10.1177/2050313X17695997. eCollection 2017.
9
Lupus Podocytopathy: An Overview.狼疮性足细胞病：概述。
Adv Chronic Kidney Dis. 2019 Sep;26(5):369-375. doi: 10.1053/j.ackd.2019.08.011.
10
Lupus podocytopathy: An important differential diagnosis of nephrotic syndrome in systemic lupus erythematosus.狼疮性足细胞病：系统性红斑狼疮中肾病综合征的重要鉴别诊断。
Indian J Nephrol. 2016 Jul-Aug;26(4):284-7. doi: 10.4103/0971-4065.169566.
引用本文的文献
1
Assessment of podocyte detachment as a pivotal step in the development of focal segmental glomerulosclerosis.评估足细胞脱落作为局灶节段性肾小球硬化发展的关键步骤。
J Egypt Natl Canc Inst. 2024 Nov 18;36(1):36. doi: 10.1186/s43046-024-00244-0.
2
Complications of Brentuximab Therapy in Patients with Hodgkin's Lymphoma and Concurrent Autoimmune Pathology-A Case Series.Brentuximab治疗霍奇金淋巴瘤合并自身免疫性疾病患者的并发症——病例系列
Hematol Rep. 2024 May 20;16(2):299-307. doi: 10.3390/hematolrep16020030.
3
Minimal change disease with papillary thyroid carcinoma: a report of two adult cases.伴有甲状腺乳头状癌的微小病变性肾小球肾炎：两例成人病例报告。
BMC Nephrol. 2023 Jul 5;24(1):202. doi: 10.1186/s12882-023-03252-9.
本文引用的文献
1
Minimal Change Disease Is Associated With Endothelial Glycocalyx Degradation and Endothelial Activation.微小病变病与内皮糖萼降解及内皮激活相关。
Kidney Int Rep. 2021 Dec 16;7(4):797-809. doi: 10.1016/j.ekir.2021.11.037. eCollection 2022 Apr.
2
Discovery of Autoantibodies Targeting Nephrin in Minimal Change Disease Supports a Novel Autoimmune Etiology.在微小病变性肾病中发现针对 Nephrin 的自身抗体支持新的自身免疫病因。
J Am Soc Nephrol. 2022 Jan;33(1):238-252. doi: 10.1681/ASN.2021060794. Epub 2021 Nov 3.
3
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?利妥昔单抗在成人微小病变性肾病和局灶节段性肾小球硬化症中的应用：已知和未知的有哪些？
Autoimmun Rev. 2020 Nov;19(11):102671. doi: 10.1016/j.autrev.2020.102671. Epub 2020 Sep 15.
4
The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series.成人或青少年晚期起病的微小病变肾病综合征的临床病程：病例系列。
Am J Kidney Dis. 2017 May;69(5):637-646. doi: 10.1053/j.ajkd.2016.10.032. Epub 2017 Jan 12.
5
Minimal Change Disease.微小病变性肾病。
Clin J Am Soc Nephrol. 2017 Feb 7;12(2):332-345. doi: 10.2215/CJN.05000516. Epub 2016 Dec 9.
6
Investigations of Glucocorticoid Action in GN.肾小球肾炎中糖皮质激素作用的研究
J Am Soc Nephrol. 2017 May;28(5):1408-1420. doi: 10.1681/ASN.2016010060. Epub 2016 Nov 28.
7
Minimal change disease and idiopathic FSGS: manifestations of the same disease.微小病变病和特发性 FSGS：同一种疾病的表现。
Nat Rev Nephrol. 2016 Dec;12(12):768-776. doi: 10.1038/nrneph.2016.147. Epub 2016 Oct 17.
8
Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis.利妥昔单抗靶向复发性局灶节段性肾小球硬化的足细胞。
Sci Transl Med. 2011 Jun 1;3(85):85ra46. doi: 10.1126/scitranslmed.3002231.
9
Pathogenesis of lipoid nephrosis: a disorder of T-cell function.脂性肾病的发病机制：一种T细胞功能紊乱疾病。
Lancet. 1974 Sep 7;2(7880):556-60. doi: 10.1016/s0140-6736(74)91880-7.
Zotero 插件